Eulerpool Terminal
The edge that pays for itself.
Current Mereo BioPharma Group forecasts and price targets in August 2026
Ø Analyst Price Targets
1.79 USD
+474.69 %
Median
1.53 USD
+392.59 %
Max
3.15 USD
Min
0.51 USD
Last Price
0.31 USD
Buy
11
Hold
3
Sell
0
The average target price for Mereo BioPharma Group is 1.79 USD. (+474.69 % above the current price)
The median price target of Mereo BioPharma Group is 1.53 USD.
Stock analysts from many renowned investment banks are closely examining the Mereo BioPharma Group stock. They conclude their professional Mereo BioPharma Group stock analyses with a clear recommendation for the Mereo BioPharma Group stock. The forecasts and price targets of professional analysts can be a good indicator of how a stock will perform in the next quarter.
| Buy | Hold | Sell | Ø Analyst Price Targets | |
|---|---|---|---|---|
| 2026-03-01 | 11 | 3 | 0 | — |
| 2026-02-01 | 11 | 3 | 0 | 1.79 USD |
| 2026-02-01 | 11 | 3 | 0 | 1.79 USD |
| 2026-01-01 | 11 | 3 | 0 | 2.12 USD |
| 2025-12-01 | 14 | 1 | 0 | 7.14 USD |
| 2025-12-01 | 14 | 1 | 0 | 7.14 USD |
Mereo BioPharma Group Stock Forecast 2026: Revenue & Earnings Estimates
Analysts expect the following revenue and earnings for Mereo BioPharma Group in the coming fiscal years:
| Fiscal year | Revenue | Net Income | Earnings per share |
|---|---|---|---|
| 2026e | 34.00 M USD | -27.00 M USD | -0.04 USD |
| 2027e | 47.00 M USD | -32.00 M USD | -0.04 USD |
| 2028e | 159.00 M USD | 36.00 M USD | 0.05 USD |